Skip to main content
Now accepting patients nationwide
Creator Partner Program

Your audience is already asking about GLP-1. Give them an answer in their language.

REMEVi partners with creators whose communities want medically supervised weight loss — in English or in Spanish, with a provider who speaks it. You recommend. We pay you for every patient who actually starts care. Not for clicks. Not for leads.

Apply to partner →

Partner payments

Flat. Per patient. On money that cleared.

Creator Partner

  • $75 when a patient you referred makes their first payment
  • $75 more when that patient is still an active patient four months later
  • $150 per patient, maximum

No percentages. No "first-month" math that changes on a prepaid plan. A payment that is refunded or disputed within 30 days doesn't count. Statements go out in the first week of each month; payments go out on the 15th.

Organizations & clinicians

Community organizations, promotoras, clinics and licensed clinicians: we work with you differently — bilingual education for your members, sponsorships and flat fees, never a payment per patient. Email partners@remevihealth.com and we'll build something that fits.

The REMEVi affiliate program in plain numbers

If you're comparing weight loss and telehealth affiliate programs, here is ours next to what the category publicly pays.

Payout per patient

REMEVi

$75 on first cleared payment + $75 at four months ($150 total)

Telehealth brand programs on the major networks

$5–$60 per sale on most brand programs (public rate cards, September 2026)

Minimum payout

REMEVi

None

Telehealth brand programs on the major networks

Typically $50–$100

Attribution window

REMEVi

90 days, first-party link

Telehealth brand programs on the major networks

Commonly 30–60 days

Network fees taken from you

REMEVi

None — direct program, personal link

Telehealth brand programs on the major networks

Network and platform cuts vary

Who can join

REMEVi

Creators, review sites, newsletters, podcasts

Telehealth brand programs on the major networks

Varies; often coupon and cashback heavy

Spanish-language patient experience

REMEVi

Native, end to end — the first fully bilingual GLP-1 telehealth platform

Telehealth brand programs on the major networks

Rare

Category figures are what programs publish on their own networks, checked September 2026, and can change. Ours are the terms on this page.

How it works

1

Apply.

Two minutes. Tell us about your audience — where they are, what language they live in, what they ask you about.

2

We talk.

A 15-minute call, then a short creative brief and a plain-language agreement. No script — you know your audience; we give you context and the rules.

3

Your link.

You get a personal link that takes people straight to the bilingual intake. Anyone who starts care through it is yours for 90 days.

4

Paid monthly.

Every month you get a statement by email — who started, who reached four months — and a payment by ACH or PayPal for everything that cleared.

Why REMEVi

First fully bilingual GLP-1 care

The whole journey is native in Spanish — the questionnaire, the provider visit, dosing instructions, the portal, billing, support. Not a translated website with English-only care behind it.

One price. No games.

Medication, provider care, shipping and support in one flat price. No membership fee, no price increase after month one, no surprise on page two. Your audience will thank you for that.

Licensed providers, licensed pharmacies

US-licensed providers prescribe after an online evaluation and labs. Medication comes from US-licensed compounding pharmacies. REMEVi is LegitScript-certified.

You keep creative control

We send a brief, not a script. One review round on your first post — for the rules below, not for your voice — then you're on your own.

The rules, so nobody gets hurt

This is prescription medicine, so there are things we can't let anyone say — including us. They're short.

You can

  • Tell your own story, in your own voice.
  • Explain what GLP-1 medications are, and name the brand-name versions to orient people.
  • Say REMEVi is bilingual, one flat price, licensed providers, licensed pharmacies.
  • Share the price and what it includes, as it appears on remevihealth.com.

You can't

  • Say REMEVi's medication is "the same as", "generic", or "just like" any brand. It's compounded; that's a different thing, and we say so.
  • Promise results, a number of pounds, or a dose.
  • Target people in Louisiana — we don't treat patients there.
  • Skip the disclosure. Every post says it's a paid partnership (#ad), that the medication is compounded and not FDA-approved, and that REMEVi isn't affiliated with any brand. We give you the exact line.

One honest heads-up: TikTok has suspended creator accounts over paid telehealth partnerships. We recommend leading on Instagram and YouTube and treating TikTok as secondary. It's your account and your call — we just won't let you find out the hard way.

Apply to partner with REMEVi

We answer every application within two business days. If it's a fit, we'll suggest a 15-minute call.

We answer every application within two business days. If it's a fit, we'll suggest a 15-minute call.

FAQ

When a patient you referred makes their first payment and it clears — not when they click, and not when they fill out the questionnaire. The second $75 pays when that patient is still active four months after that first payment. Statements go out in the first week of each month; payments go out on the 15th.

Your personal link carries your partner code into the intake, and we attribute that person to you for 90 days from the click. If they come back later and start through the site directly inside those 90 days, they're still yours. Someone who is already a REMEVi patient can't be referred.

A first payment that's refunded or disputed within 30 days doesn't count. Everything else stands.

Please do. That's the point. The patient experience is fully in Spanish, and we'll give you approved Spanish copy for the disclosure and the basics.

You can name the brand-name medications to explain what GLP-1s are. You can't say REMEVi's medication is the same as, a generic of, or "just like" any of them. It's a compounded medication from a licensed pharmacy, and every post says so.

Yes, on different terms — we don't pay licensed clinicians or organizations per patient, ever. Email partners@remevihealth.com and we'll set up education, a flat sponsorship, or a community session instead.

Yes — a direct one. REMEVi pays creators, review sites, newsletters and podcasts a flat amount for each patient who starts medically supervised GLP-1 weight-loss care through their personal link. There is no network to join and no fee taken from your payout.

$75 when a patient you referred makes their first payment and it clears, and $75 more when they're still an active patient four months later — $150 per patient, no minimum payout, paid monthly.

No. It's run directly: you apply on this page, we send you a personal link and a short brief, and statements come from us. If you already promote telehealth or health programs through a network, you can run REMEVi alongside them — the program is non-exclusive.

A fit: creators, reviewers, newsletter writers and podcast hosts whose audience asks about GLP-1 weight loss, in English or Spanish. Not a fit: coupon, cashback and toolbar sites, incentivised or paid-search traffic on our brand name, and anyone who wants to promise results. Licensed clinicians and community organizations are welcome on different terms (see above).

Questions before you apply? Write to partners@remevihealth.com — a person answers, usually the same day.

Free · no card required